Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-11-16

Clinical Trial Update: Relapse of Ankylosing Spondylitis Patients Withdrawal Etanercept After Clinical Remission: a Following-up Study [Phase 4]

View source ↗

Summary

A Phase 4 follow-up study evaluates relapse in ankylosing spondylitis after withdrawal of etanercept in patients who had achieved clinical remission.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Etanercept (etanercept)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Spondylitis, Ankylosing, Recurrence | Phase 4 | Status: COMPLETED